Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.

Grieves JL, Yin Z, Garcia-Sastre A, Mena I, Peeples ME, Risman HP, Federman H, Sandoval MJ, Durbin RK, Durbin JE.

Vaccine. 2018 Jun 18;36(26):3842-3852. doi: 10.1016/j.vaccine.2018.04.089. Epub 2018 May 18.

2.

Type III interferon is a critical regulator of innate antifungal immunity.

Espinosa V, Dutta O, McElrath C, Du P, Chang YJ, Cicciarelli B, Pitler A, Whitehead I, Obar JJ, Durbin JE, Kotenko SV, Rivera A.

Sci Immunol. 2017 Oct 6;2(16). pii: eaan5357. doi: 10.1126/sciimmunol.aan5357.

3.

Contribution of type III interferons to antiviral immunity: location, location, location.

Kotenko SV, Durbin JE.

J Biol Chem. 2017 May 5;292(18):7295-7303. doi: 10.1074/jbc.R117.777102. Epub 2017 Mar 13. Review.

4.

Correction: Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections.

Lin JD, Feng N, Sen A, Balan M, Tseng HC, McElrath C, Smirnov SV, Peng J, Yasukawa LL, Durbin RK, Durbin JE, Greenberg HB, Kotenko SV.

PLoS Pathog. 2016 Jun 15;12(6):e1005726. doi: 10.1371/journal.ppat.1005726. eCollection 2016 Jun.

5.

Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections.

Lin JD, Feng N, Sen A, Balan M, Tseng HC, McElrath C, Smirnov SV, Peng J, Yasukawa LL, Durbin RK, Durbin JE, Greenberg HB, Kotenko SV.

PLoS Pathog. 2016 Apr 29;12(4):e1005600. doi: 10.1371/journal.ppat.1005600. eCollection 2016 Apr. Erratum in: PLoS Pathog. 2016 Jun 15;12 (6):e1005726.

6.

Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity.

Hendricks MR, Lashua LP, Fischer DK, Flitter BA, Eichinger KM, Durbin JE, Sarkar SN, Coyne CB, Empey KM, Bomberger JM.

Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1642-7. doi: 10.1073/pnas.1516979113. Epub 2016 Jan 4.

7.
8.

Animal models of respiratory syncytial virus infection and disease.

Sacco RE, Durbin RK, Durbin JE.

Curr Opin Virol. 2015 Aug;13:117-22. doi: 10.1016/j.coviro.2015.06.003. Epub 2015 Jul 11. Review.

9.

Inflammatory impact of IFN-γ in CD8+ T cell-mediated lung injury is mediated by both Stat1-dependent and -independent pathways.

Ramana CV, DeBerge MP, Kumar A, Alia CS, Durbin JE, Enelow RI.

Am J Physiol Lung Cell Mol Physiol. 2015 Apr 1;308(7):L650-7. doi: 10.1152/ajplung.00360.2014. Epub 2015 Jan 23.

10.

Interferon induction and function at the mucosal surface.

Durbin RK, Kotenko SV, Durbin JE.

Immunol Rev. 2013 Sep;255(1):25-39. doi: 10.1111/imr.12101. Review.

11.

Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.

Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D, Durbin JE, Ramilo O, Mejias A, Flaño E.

J Virol. 2012 May;86(10):5422-36. doi: 10.1128/JVI.06757-11. Epub 2012 Mar 7.

12.

Induction and function of type I and III interferon in response to viral infection.

Levy DE, Marié IJ, Durbin JE.

Curr Opin Virol. 2011 Dec;1(6):476-86. doi: 10.1016/j.coviro.2011.11.001. Review.

13.

Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation.

Raven JF, Williams V, Wang S, Tremblay ML, Muller WJ, Durbin JE, Koromilas AE.

Cell Cycle. 2011 Mar 1;10(5):794-804. Epub 2011 Mar 1.

PMID:
21311224
14.

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.

Jewell NA, Cline T, Mertz SE, Smirnov SV, Flaño E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE.

J Virol. 2010 Nov;84(21):11515-22. doi: 10.1128/JVI.01703-09. Epub 2010 Aug 25. Erratum in: J Virol. 2011 Jan;85(1):650.

15.

Mapping the anatomy of respiratory syncytial virus infection of the upper airways in chinchillas (Chinchilla lanigera).

Grieves JL, Jurcisek JA, Quist B, Durbin RK, Peeples ME, Durbin JE, Bakaletz LO.

Comp Med. 2010 Jun;60(3):225-32.

16.

Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection.

Barbi J, Snider HM, Bhardwaj N, Lezama-Dávila CM, Durbin JE, Satoskar AR.

FASEB J. 2009 Nov;23(11):3990-9. doi: 10.1096/fj.09-138057. Epub 2009 Jul 29.

17.

STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection.

Moore ML, Newcomb DC, Parekh VV, Van Kaer L, Collins RD, Zhou W, Goleniewska K, Chi MH, Mitchell D, Boyce JA, Durbin JE, Sturkie C, Peebles RS Jr.

J Immunol. 2009 Aug 1;183(3):2016-26. doi: 10.4049/jimmunol.0803167. Epub 2009 Jul 8.

18.

Methods used to study respiratory virus infection.

Flaño E, Jewell NA, Durbin RK, Durbin JE.

Curr Protoc Cell Biol. 2009 Jun;Chapter 26:Unit 26.3. doi: 10.1002/0471143030.cb2603s43.

19.

Stat1 phosphorylation determines Ras oncogenicity by regulating p27 kip1.

Wang S, Raven JF, Durbin JE, Koromilas AE.

PLoS One. 2008;3(10):e3476. doi: 10.1371/journal.pone.0003476. Epub 2008 Oct 22.

20.

Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.

Moore ML, Chi MH, Goleniewska K, Durbin JE, Peebles RS Jr.

Viral Immunol. 2008 Sep;21(3):327-39. doi: 10.1089/vim.2008.0003.

21.

Influenza A virus inhibits alveolar fluid clearance in BALB/c mice.

Wolk KE, Lazarowski ER, Traylor ZP, Yu EN, Jewell NA, Durbin RK, Durbin JE, Davis IC.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):969-76. doi: 10.1164/rccm.200803-455OC. Epub 2008 Aug 8.

22.

Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection.

Weslow-Schmidt JL, Jewell NA, Mertz SE, Simas JP, Durbin JE, Flaño E.

J Virol. 2007 Sep;81(18):9778-89. Epub 2007 Jul 11.

23.

Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo.

Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS Jr, Bakaletz LO, Durbin RK, Flaño E, Durbin JE.

J Virol. 2007 Sep;81(18):9790-800. Epub 2007 Jul 11.

24.

Respiratory virus infection in infants and children.

Hammond S, Chenever E, Durbin JE.

Pediatr Dev Pathol. 2007 May-Jun;10(3):172-80. Review.

PMID:
17535096
25.

STAT1 is involved in the pathogenesis of murine allergic rhinitis.

Hattori H, Rosas LE, Okano M, Durbin JE, Nishizaki K, Satoskar AR.

Am J Rhinol. 2007 Mar-Apr;21(2):241-7.

PMID:
17424888
26.

Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge.

Tompkins SM, Lin Y, Leser GP, Kramer KA, Haas DL, Howerth EW, Xu J, Kennett MJ, Durbin RK, Durbin JE, Tripp R, Lamb RA, He B.

Virology. 2007 May 25;362(1):139-50. Epub 2007 Jan 23.

27.

Cutting edge: STAT1 and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani.

Rosas LE, Snider HM, Barbi J, Satoskar AA, Lugo-Villarino G, Keiser T, Papenfuss T, Durbin JE, Radzioch D, Glimcher LH, Satoskar AR.

J Immunol. 2006 Jul 1;177(1):22-5.

28.

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.

Martinez-Sobrido L, Gitiban N, Fernandez-Sesma A, Cros J, Mertz SE, Jewell NA, Hammond S, Flano E, Durbin RK, García-Sastre A, Durbin JE.

J Virol. 2006 Feb;80(3):1130-9.

29.

TNF receptor-associated factor 6-dependent CD40 signaling primes macrophages to acquire antimicrobial activity in response to TNF-alpha.

Andrade RM, Wessendarp M, Portillo JA, Yang JQ, Gomez FJ, Durbin JE, Bishop GA, Subauste CS.

J Immunol. 2005 Nov 1;175(9):6014-21.

30.

Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels.

Hashimoto K, Durbin JE, Zhou W, Collins RD, Ho SB, Kolls JK, Dubin PJ, Sheller JR, Goleniewska K, O'Neal JF, Olson SJ, Mitchell D, Graham BS, Peebles RS Jr.

J Allergy Clin Immunol. 2005 Sep;116(3):550-7.

PMID:
16159623
31.

Role for innate IFNs in determining respiratory syncytial virus immunopathology.

Johnson TR, Mertz SE, Gitiban N, Hammond S, Legallo R, Durbin RK, Durbin JE.

J Immunol. 2005 Jun 1;174(11):7234-41.

32.

Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus.

Gitiban N, Jurcisek JA, Harris RH, Mertz SE, Durbin RK, Bakaletz LO, Durbin JE.

J Virol. 2005 May;79(10):6035-42.

33.

Respiratory syncytial virus-induced immunoprotection and immunopathology.

Durbin JE, Durbin RK.

Viral Immunol. 2004;17(3):370-80. Review.

PMID:
15357903
34.

Activation induced differential regulation of stem cell antigen-1 (Ly-6A/E) expression in murine B cells.

Chen HC, Frissora F, Durbin JE, Muthusamy N.

Cell Immunol. 2003 Sep;225(1):42-52.

PMID:
14643303
35.

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

Stojdl DF, Lichty BD, tenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J, Bell JC.

Cancer Cell. 2003 Oct;4(4):263-75.

36.

Anatomy of the nasal cavity in the chinchilla.

Jurcisek JA, Durbin JE, Kusewitt DF, Bakaletz LO.

Cells Tissues Organs. 2003;174(3):136-52.

PMID:
12835577
37.
38.

Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection.

Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA.

J Immunol. 2002 Oct 15;169(8):4279-87.

39.

PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent.

Durbin RK, Mertz SE, Koromilas AE, Durbin JE.

Viral Immunol. 2002;15(1):41-51.

PMID:
11952146
40.

The role of IFN in respiratory syncytial virus pathogenesis.

Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS.

J Immunol. 2002 Mar 15;168(6):2944-52.

42.
43.

Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR.

Wong AH, Durbin JE, Li S, Dever TE, Decker T, Koromilas AE.

J Biol Chem. 2001 Apr 27;276(17):13727-37. Epub 2001 Jan 25.

44.

Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox.

Nguyen KB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA.

Nat Immunol. 2000 Jul;1(1):70-6.

PMID:
10881178
45.

Type I IFN modulates innate and specific antiviral immunity.

Durbin JE, Fernandez-Sesma A, Lee CK, Rao TD, Frey AB, Moran TM, Vukmanovic S, García-Sastre A, Levy DE.

J Immunol. 2000 Apr 15;164(8):4220-8.

46.

Control of Sindbis virus infection by antibody in interferon-deficient mice.

Byrnes AP, Durbin JE, Griffin DE.

J Virol. 2000 Apr;74(8):3905-8.

47.

Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.

García-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T.

Virology. 1998 Dec 20;252(2):324-30.

49.

The role of interferon in influenza virus tissue tropism.

García-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE.

J Virol. 1998 Nov;72(11):8550-8.

50.

Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway.

Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman JW, Sedmak DD.

J Exp Med. 1998 Mar 2;187(5):675-83.

Supplemental Content

Loading ...
Support Center